Dr. Marcus Meinardi leads AXIM Biotech’s AX-1602 human trials with cannabigerol (CBG) and other cannabinoids for psoriasis and eczema at Maurits Clinics in The Hague, The Netherlands.
Dr. Marcus Meinardi leads AXIM Biotech’s AX-1602 human trials with cannabigerol (CBG) and other cannabinoids for psoriasis and eczema at Maurits Clinics in The Hague, The Netherlands.